Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Pediatric Neuroblastoma

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCPED1489

    01/07/2016

    Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers

    Treatment

    COGANBL1232

    08/20/2014

    Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

    Treatment

    VICCPED1249

    08/06/2012

    An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma


    Print this page for your doctor